ECMM Candida Registry - CandiReg

计划入组 2,000 人 · 首次发布于 2018 年 3 月 1 日

Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age

计划入组 1,500 人

Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study

计划入组 251 人 · 首次发布于 2024 年 1 月 5 日

Candicidin

C₅₉H₈₄N₂O₁₈

Candida albicans(Candin)

Candi5V

Scynexis

United States

Oculis

Switzerland

Lexicon Pharmaceuticals

United States

Biodegradable Brain Implants Show Promise in Preventing Glioblastoma Recurrence Through Immune System Reprogramming

Nielsen BioSciences' CANDIN Achieves Primary Endpoint in First Phase 3 Trial for Common Warts Treatment

Basilea Secures $39 Million BARDA Funding to Advance Novel Antifungal Candidates Fosmanogepix and BAL2062